Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Launched by LG CHEM · May 22, 2012
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term safety and effectiveness of growth hormone treatments in children who have certain conditions that can affect their growth, such as Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Failure, being Small for Gestational Age, and Idiopathic Short Stature. The goal is to see how well these treatments work over time and to ensure they are safe for kids.
To participate in the trial, children must be at least 2 years old and diagnosed with one of the conditions mentioned. Parents or guardians will need to provide written consent for their child to join. The trial is currently looking for participants, and it welcomes children of all genders. If a child joins this study, they can expect regular check-ups to monitor their growth and health while receiving the growth hormone treatment. This research is important as it may help improve the understanding and management of growth issues in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • short stature children aged 2 years or more
- • children with GHD,TS, CRF, SGA or ISS
- • written informed consent from the person, person's parent or legal guardian
About Lg Chem
LG Chem is a leading global chemical and advanced materials company based in South Korea, recognized for its commitment to innovation and sustainability in the life sciences sector. With a robust portfolio that spans pharmaceuticals, biotechnology, and advanced materials, LG Chem leverages cutting-edge research and development to drive breakthroughs in healthcare. The company is dedicated to improving patient outcomes through the development of novel therapies and drug delivery systems, underscoring its mission to enhance quality of life through science and technology. As a clinical trial sponsor, LG Chem prioritizes rigorous scientific standards and ethical practices to ensure the safety and efficacy of its therapeutic candidates.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
HW Chae, M.D.
Principal Investigator
Kangnam severance hospital
KS Sim, M.D.
Principal Investigator
Kangdong KyungHee University hospital
IT Hwang, M.D.
Principal Investigator
Kangdong Sacred Heart Hospital
SC Chung, M.D.
Principal Investigator
Konkook University hospital
CW Ko, M.D.
Principal Investigator
Kyungpook National University Hospital
HS Kim, M.D.
Principal Investigator
Keimyung University hospital
YJ Lee, M.D.
Principal Investigator
Korea University
KH Lee, M.D.
Principal Investigator
Korea University Anam Hospital
JH Lee, M.D.
Principal Investigator
Kosin university hospital
JS Yu, M.D.
Principal Investigator
Dankook University
JH Yu, M.D.
Principal Investigator
Dong-A University Hospital
SY Lee, M.D.
Principal Investigator
SMG-SNU Boramae Medical Center
WY Chung, M.D.
Principal Investigator
Inje University
Yl Shin, M.D.
Principal Investigator
Buchun Soonchunhyang university hospital
CY Kim, M.D.
Principal Investigator
daejin medical center
DK Jin, M.D.
Principal Investigator
Samsung Medical Center
MJ Park, M.D.
Principal Investigator
Inje University
CH Shin, M.D.
Study Chair
Seoul National University Hospital
BK Suh, M.D.
Principal Investigator
Seoul St. Mary's Hospital
HW Yoo, M.D.
Principal Investigator
Asan Medical Center
MH Jung, M.D.
Principal Investigator
Yeouide St. Mary's hospital
SH Park, M.D.
Principal Investigator
St Vincent's Hospital
DH Kim, M.D.
Principal Investigator
Sowha children's hospital
DH Lee, M.D.
Principal Investigator
Seoul Soonchunhyang university hospital
HS Kim, M.D.
Principal Investigator
Sinchon severance hospital
JS Hwang, M.D.
Principal Investigator
Ajou University School of Medicine
SY Kim, M.D.
Principal Investigator
Pusan National University Yangsan Hospital
JD Kim, M.D.
Principal Investigator
Wonkwang university school of medicine & hospital
HS Han, M.D.
Principal Investigator
Chungbuk National University Hospital
KH Lee, M.D.
Principal Investigator
Wonkwang University Sanbon Medical Center
EK Yoo, M.D.
Principal Investigator
Bunsangcha hospital
BK Lim, M.D.
Principal Investigator
Wonju Christian Hospital
JH Kang, M.D.
Principal Investigator
Eulji University Hospital
JY Seo, M.D.
Principal Investigator
Eulji General Hospital
HS Kim, M.D.
Principal Investigator
ehwa university medical center
JE Lee, M.D.
Principal Investigator
Inha University Hospital
JH Kim, M.D.
Principal Investigator
Inje University
CJ Kim, M.D.
Principal Investigator
Chonnam National University Hospital
DY Lee, M.D.
Principal Investigator
Chonbuk National University Hospital
KS Shin, M.D.
Principal Investigator
Jeju National University Hospital
IT Hwang, M.D.
Principal Investigator
Hallym University Medical Center
SM Lee, M.D.
Principal Investigator
Hanyang University
KH Lee, M.D.
Principal Investigator
Korea University Guro Hospital
KS Jo, M.D.
Principal Investigator
Bucheon St. Mary's Hospital
SY Ahn, M.D.
Principal Investigator
KangWon National University Hospital
PS Oh, M.D.
Principal Investigator
Chuncheon Sacred Heart Hospital
S Yang, M.D.
Principal Investigator
Hallym University Kangnam Sacred Heart Hospital
EY Kim, M.D.
Principal Investigator
Chosun University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials